IndiaCOVID-19Ministry of Health and Family WelfareHealth

COVID – 19 Vaccination Update – Day 382

India’s cumulative vaccination coverage crosses 167.21 crore. More than 50 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage has crossed 167.21 Crore (167,21,94,503) today. More than 50 lakh (50,63,394) Vaccine Doses have been administered till 7 pm today. More than 1.29 Crore (1,29,56,314) Precaution Doses for the identified categories of beneficiaries for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10396184
2nd Dose 9878771
Precaution Dose 3446454
FLWs 1st Dose 18397492
2nd Dose 17262623
Precaution Dose 4095972
Age Group 15-18 years 1st Dose 47144423
2nd Dose 1081838
Age Group 18-44 years 1st Dose 541967745
2nd Dose 408192353
Age Group 45-59 years 1st Dose 200463995
2nd Dose 172164103
Over 60 years 1st Dose 125011540
2nd Dose 107277122
Precaution Dose 5413888
Cumulative 1st dose administered 943381379
Cumulative 2nd dose administered 715856810
Precaution Dose 12956314
Total 1672194503

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 1st February, 2022 (382nd Day)
HCWs 1st Dose 338
2nd Dose 5728
Precaution Dose 55044
FLWs 1st Dose 548
2nd Dose 11569
Precaution Dose 130088
Age Group 15-18 years 1st Dose 463904
2nd Dose 712090
Age Group 18-44 years 1st Dose 618743
2nd Dose 1865462
Age Group 45-59 years 1st Dose 108958
2nd Dose 476660
Over 60 years 1st Dose 80191
2nd Dose 280623
Precaution Dose 253448
Cumulative 1st dose administered 1272682
Cumulative 2nd dose administered 3352132
Precaution Dose 438580
Total 5063394

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button